National Vision Holdings, Inc.

EYE ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017
Revenue $1.99B $1.82B $1.76B $1.64B $1.71B $1.72B $1.54B $1.38B
Cost of Revenue $819.5M $764.1M $734.7M $667.7M $786.6M $806.5M $713.6M $637.0M
Gross Profit $1.17B $1.06B $1.02B $977.0M $925.1M $917.8M $823.3M $738.3M
Gross Margin 58.8% 58.1% 58.2% 59.4% 54.0% 53.2% 53.6% 53.7%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $1.02B $938.5M $904.8M $832.6M $725.0M $744.5M $687.5M $600.0M
Operating Income $58.8M $-10.4M $24.5M $52.8M $87.0M $73.6M $42.4M $64.3M
Operating Margin 3.0% -0.6% 1.4% 3.2% 5.1% 4.3% 2.8% 4.7%
Interest Expense — — — $25.6M $48.3M $33.3M $37.3M $55.5M
Pretax Income $41.7M $-25.7M $9.6M $52.3M $38.7M $30.5M $4.9M $4.2M
Income Tax Expense $12.1M $1.5M $6.0M $15.5M $2.4M $-2.3M $-18.8M $-38.9M
Net Income $29.6M $-28.5M $-65.9M $42.1M $36.3M $32.8M $23.7M $43.1M
Net Margin 1.5% -1.6% -3.8% 2.6% 2.1% 1.9% 1.5% 3.1%
EPS (Basic) $0.37 $-0.36 $-0.84 $0.53 $0.45 $0.42 $0.31 $0.72
EPS (Diluted) $0.37 $-0.36 $-0.84 $0.52 $0.44 $0.40 $0.30 $0.70
Shares Outstanding (Basic) 79.1M 78.6M 78.3M 79.8M 80.6M 78.6M 75.9M 59.9M
Shares Outstanding (Diluted) 80.6M 78.6M 78.6M 80.3M 82.8M 81.7M 79.0M 62.0M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →